PK/PD for prevention of resistance: clinical data

• Infect Control Hosp Epidemiol 2000 Jan;21(1 Suppl):S9-11Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.Hyatt JM, Schentag JJ OBJECTIVE: To determine risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa. METHODS: Patients with cultures (any site) positive for Paeruginosa, susceptible to ciprofloxacin, between January 1993 and December 1996 were identified using a computerized database

Previous slide

Next slide

Back to first slide

View graphic version